Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

Insulin receptor alternative splicing is regulated by insulin signaling and modulates beta cell survival.

Malakar P, Chartarifsky L, Hija A, Leibowitz G, Glaser B, Dor Y, Karni R.

Sci Rep. 2016 Aug 16;6:31222. doi: 10.1038/srep31222.

2.

Differential Expression of IR-A, IR-B and IGF-1R in Endometrial Physiology and Distinct Signature in Adenocarcinoma.

Flannery CA, Saleh FL, Choe GH, Selen DJ, Kodaman PH, Kliman HJ, Wood TL, Taylor HS.

J Clin Endocrinol Metab. 2016 Jul;101(7):2883-91. doi: 10.1210/jc.2016-1795. Epub 2016 Apr 18.

PMID:
27088794
3.

Obesity and cancer, a case for insulin signaling.

Poloz Y, Stambolic V.

Cell Death Dis. 2015 Dec 31;6:e2037. doi: 10.1038/cddis.2015.381. Review.

4.

Nephrin Contributes to Insulin Secretion and Affects Mammalian Target of Rapamycin Signaling Independently of Insulin Receptor.

Villarreal R, Mitrofanova A, Maiguel D, Morales X, Jeon J, Grahammer F, Leibiger IB, Guzman J, Fachado A, Yoo TH, Busher Katin A, Gellermann J, Merscher S, Burke GW, Berggren PO, Oh J, Huber TB, Fornoni A.

J Am Soc Nephrol. 2016 Apr;27(4):1029-41. doi: 10.1681/ASN.2015020210. Epub 2015 Sep 23.

5.

Nephrin Trafficking beyond the Kidney--Role in Glucose-Stimulated Insulin Secretion in β Cells.

Lehtonen S, Jalanko H.

J Am Soc Nephrol. 2016 Apr;27(4):965-8. doi: 10.1681/ASN.2015080960. Epub 2015 Sep 23. No abstract available.

6.

The paired basic amino acid-cleaving enzyme 4 (PACE4) is involved in the maturation of insulin receptor isoform B: an opportunity to reduce the specific insulin receptor-dependent effects of insulin-like growth factor 2 (IGF2).

Kara I, Poggi M, Bonardo B, Govers R, Landrier JF, Tian S, Leibiger I, Day R, Creemers JW, Peiretti F.

J Biol Chem. 2015 Jan 30;290(5):2812-21. doi: 10.1074/jbc.M114.592543. Epub 2014 Dec 19.

7.

Insulin signaling: implications for podocyte biology in diabetic kidney disease.

Coward R, Fornoni A.

Curr Opin Nephrol Hypertens. 2015 Jan;24(1):104-10. doi: 10.1097/MNH.0000000000000078.

8.

Insulin regulates carboxypeptidase E by modulating translation initiation scaffolding protein eIF4G1 in pancreatic β cells.

Liew CW, Assmann A, Templin AT, Raum JC, Lipson KL, Rajan S, Qiang G, Hu J, Kawamori D, Lindberg I, Philipson LH, Sonenberg N, Goldfine AB, Stoffers DA, Mirmira RG, Urano F, Kulkarni RN.

Proc Natl Acad Sci U S A. 2014 Jun 3;111(22):E2319-28. doi: 10.1073/pnas.1323066111. Epub 2014 May 19.

9.

D-chiro-inositol glycan stimulates insulin secretion in pancreatic β cells.

Lazarenko R, Geisler J, Bayliss D, Larner J, Li C.

Mol Cell Endocrinol. 2014 Apr 25;387(1-2):1-7. doi: 10.1016/j.mce.2014.02.004. Epub 2014 Feb 14.

10.

Insulin downregulates the expression of the Ca2+-activated nonselective cation channel TRPM5 in pancreatic islets from leptin-deficient mouse models.

Colsoul B, Jacobs G, Philippaert K, Owsianik G, Segal A, Nilius B, Voets T, Schuit F, Vennekens R.

Pflugers Arch. 2014 Mar;466(3):611-21. doi: 10.1007/s00424-013-1389-7. Epub 2013 Nov 13.

11.

Insulin receptor phosphorylation by endogenous insulin or the insulin analog AspB10 promotes mammary tumor growth independent of the IGF-I receptor.

Gallagher EJ, Alikhani N, Tobin-Hess A, Blank J, Buffin NJ, Zelenko Z, Tennagels N, Werner U, LeRoith D.

Diabetes. 2013 Oct;62(10):3553-60. doi: 10.2337/db13-0249. Epub 2013 Jul 8.

12.

Glucagon regulates its own synthesis by autocrine signaling.

Leibiger B, Moede T, Muhandiramlage TP, Kaiser D, Vaca Sanchez P, Leibiger IB, Berggren PO.

Proc Natl Acad Sci U S A. 2012 Dec 18;109(51):20925-30. doi: 10.1073/pnas.1212870110. Epub 2012 Dec 3.

13.

Insulin signaling and insulin resistance.

Beale EG.

J Investig Med. 2013 Jan;61(1):11-4. doi: 10.2310/JIM.0b013e3182746f95. Review.

14.

CTCF mediates effect of insulin on glucagon expression.

Tsui S, Gao J, Wang C, Lu L.

Exp Cell Res. 2012 May 1;318(8):887-95. doi: 10.1016/j.yexcr.2012.03.001. Epub 2012 Mar 8.

15.

Transcriptional regulation of glucose sensors in pancreatic β-cells and liver: an update.

Bae JS, Kim TH, Kim MY, Park JM, Ahn YH.

Sensors (Basel). 2010;10(5):5031-53. doi: 10.3390/s100505031. Epub 2010 May 19. Review.

16.

Altered insulin receptor signalling and β-cell cycle dynamics in type 2 diabetes mellitus.

Folli F, Okada T, Perego C, Gunton J, Liew CW, Akiyama M, D'Amico A, La Rosa S, Placidi C, Lupi R, Marchetti P, Sesti G, Hellerstein M, Perego L, Kulkarni RN.

PLoS One. 2011;6(11):e28050. doi: 10.1371/journal.pone.0028050. Epub 2011 Nov 30.

17.

Class II phosphoinositide 3-kinase C2alpha: what we learned so far.

Mazza S, Maffucci T.

Int J Biochem Mol Biol. 2011;2(2):168-182. Epub 2011 Apr 22.

18.

Exogenous insulin enhances glucose-stimulated insulin response in healthy humans independent of changes in free fatty acids.

Lopez X, Cypess A, Manning R, O'Shea S, Kulkarni RN, Goldfine AB.

J Clin Endocrinol Metab. 2011 Dec;96(12):3811-21. doi: 10.1210/jc.2011-0627. Epub 2011 Sep 28.

19.

Research resource: New and diverse substrates for the insulin receptor isoform A revealed by quantitative proteomics after stimulation with IGF-II or insulin.

Morcavallo A, Gaspari M, Pandini G, Palummo A, Cuda G, Larsen MR, Vigneri R, Belfiore A.

Mol Endocrinol. 2011 Aug;25(8):1456-68. doi: 10.1210/me.2010-0484. Epub 2011 Jun 16.

20.

Non-invasive in vivo imaging of pancreatic β-cell function and survival - a perspective.

Leibiger IB, Caicedo A, Berggren PO.

Acta Physiol (Oxf). 2012 Feb;204(2):178-85. doi: 10.1111/j.1748-1716.2011.02301.x. Epub 2011 May 28. Review.

Supplemental Content

Support Center